(2S,4S,4''R)-2'',2''-Dimethyl-[4,4''-bi-1,3-dioxolane]-2-methanol 2-Benzoate is an intermediate used in the synthesis of Troxacitabine (T805580), which is a nucleoside analogue with potential anticancer activity. Troxacitabine have been studied in patients with refractory lymphoproliferative diseases.